1. Abrams JS, Moore TD, Friedman M (1994) New chemotherapeutic agents for breast cancer. Cancer 74: 1164–1176
2. Alexander HR, Candela FC, Dershaw DD, Kinne DW (1990) Needle-localized mammographic lesions: results and evolving treatment strategy.Arch Surg 125: 1441
3. Allred DC, Clark GM, Tandon AK et al. (1992) HER-2/neu in node-negative breast cancer: Prognostic significance of over-expression influenced by the presence of in situ carcinoma.) Clin Oncol 10: 599–605
4. American Society of Human Genetics (ASHG) (2000) 50th meeting of the October 4–7
5. Andersen TL, Holm R, Nesland JM, Heimdal KR, Ottestad L, Borresen AL (1993) Prognostic significance ofTP53 alterations in breast carcinoma. Bri Cancer 68: 540–548